Cargando…
Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most malignant form of gastrointestinal tumor and is the fourth leading cause of deaths due to cancer in Japan. This cancer shows a poor outcome due to the difficulty of its early diagnosis and its rapid growth. Once this disease becomes clinically evid...
Autor principal: | Satoh, Kennichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926932/ https://www.ncbi.nlm.nih.gov/pubmed/33671729 http://dx.doi.org/10.3390/diagnostics11020375 |
Ejemplares similares
-
Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
por: Ideno, Noboru, et al.
Publicado: (2020) -
Regulators of epithelial mesenchymal transition in pancreatic cancer
por: Hamada, Shin, et al.
Publicado: (2012) -
MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma
por: Satoh, Kennichi, et al.
Publicado: (2012) -
Proteomic biomarkers in body fluids associated with pancreatic cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2018) -
Duodenal Metastasis from a Pancreatic Neuroendocrine Neoplasm
por: Koiwai, Akinobu, et al.
Publicado: (2020)